Dr. Chiung-Mei Lu is a board member. Dr. Lu obtained her Bachelor of Science in Nutritional Science from TaiPei Medical University and received her Ph.D. from UAB (1991) in Neuroscience. After postdoctoral training at UAB, she joined Research Genetics to lead their microarray development team in charge of customer support and training. After Research Genetics was acquired by Invitrogen, Dr. Lu joined Genaco to serve as COO. Under Dr. Lu’s management, Genaco excelled with limited funding and resources. She directed a team to work with the FDA consultants to build Quality Systems for the company and helped prioritize research and development projects and coordinate marketing efforts.
Ms. Sue Whitehead is a board member of iCubate. Ms. Whitehead received her Bachelor of Science in Computer Science from Texas State University. Ms. Whitehead serves on the board of Diatherix Laboratories, a provider of clinical laboratory services for detection of infectious diseases. Ms. Whitehead also serves on the HudsonAlpha Foundation Board, which helps ensure long-term growth, sustainability and security for HudsonAlpha’s future of providing improvement of human health and quality of life. A seasoned investor in life sciences start-up companies, Ms. Whitehead provides near and long term financial strategic counsel for the company.
Mr. Tom Young is a board member of iCubate. Mr. Young is the founder and Chief Executive Officer of Kord Technologies, a consulting and technical services company with various Department of Defense and NASA customers and contracts. Prior to founding Kord, Mr. Young was the Chief Executive Officer of Qualitest/Vintage Pharmaceuticals, one of the nation’s largest drug companies. Prior to joining Qualitest, he served as Executive Vice-President at Intergraph Corporation, a Huntsville-based software and services company. Additionally, Mr. Young was Chief of Staff for U.S. Senator Richard C. Shelby (R-AL).